Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Advanced Tumours × toripalimab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 8 Melanoma 5 Colorectal Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Stomach Neoplasms 3 Lymphoma 3 Carcinoma, Hepatocellular 3 Squamous Cell Carcinoma of Head and Neck 2 Neoplasm Metastasis 2 Nasopharyngeal Carcinoma 2 Carcinoma, Renal Cell 2 Advanced Solid Tumor 2 Solid Tumor 1 Small Cell Lung Carcinoma 1 Skin Neoplasms 1 Sarcoma 1 Primary Condition: Advanced Tumors 1 Neuroendocrine Tumors 1 Mouth Neoplasms 1 Lung Neoplasms 1 Locoregionally Advanced Laryngo-hypopharyngeal Squamous Cell Cancer 1 Liver Neoplasms 1 Kidney Neoplasms 1 High-Risk Resectable NSCLC 1 Esophageal Squamous Cell Carcinoma 1 Esophageal Neoplasms 1 Chondrosarcoma 1 Carcinoma, Transitional Cell 1 Brain Neoplasms 1 Advanced Tumours 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04737122 2023-10-10

Study of LM-061 in Subjects in Advanced Tumors

LaNova Medicines Limited

Phase 1 Terminated

Advanced Tumours

Data powered by HemOnc (CC BY 4.0) Colophon ⚡